Reagan Simpson
Family Medicine · Ramsey, MNNPI 1730564402
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $740 and has fallen 96.3% since, to $27 in 2024. Among family medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$470
- AbbVie$395
- Pfizer$247
- Lilly USA, LLC$237
- Amgen$189
- AstraZeneca$154
- plus $342 from 11 others
What the payments were for
- Food & beverage$2,034100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $470 |
| AbbVie(2 entities) | 23 | $395 |
| Pfizer | 15 | $247 |
| Lilly USA, LLC | 15 | $237 |
| Amgen(2 entities) | 13 | $189 |
| AstraZeneca | 7 | $154 |
| Amarin Pharma, Inc. | 9 | $133 |
| Boehringer Ingelheim | 3 | $47 |
| Novartis | 2 | $31 |
| Johnson & Johnson | 2 | $27 |
| Medicure Pharma Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Abbott | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$2,034 in reported general payments places this provider in the 95th percentile of 1,162 family medicine providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 35 | $265 |
| Levothyroxine Sodium | 22 | $152 |
| Omeprazole | 13 | $104 |
| Metformin Hcl | 20 | $96 |
| Amlodipine Besylate | 23 | $79 |
| Lisinopril | 17 | $52 |
| Hydrochlorothiazide | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ramsey
- Amanda LovoldSt Cloud$387K
- Robert MarshMinnetonka$300K
- Taylor MertzMoorhead$176K
- Justin YoungTracy$93K
- Gerard SpoelhofDuluth$75K
- Martha MasciopintoCottage Grove$50K
- Glenn DetlefsenRosemount$39K
- Amy GilbertSaint Paul$27K
- Kevin PetersonMinneapolis$25K
- Joseph McGrathWabasha$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.